Background illustration for clinical trials search

Paid Clinical Trials Calgary

Discover 521 paid clinical trials in Calgary, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Brief Skills for Safer Living (Brief-SfSL)

for
Suicide Prevention, Suicide, Suicide and Self-harm, Depression,
Location: Calgary, Red Deer, Edmonton, Kelowna, Saskatoon,
Sponsor: Unity Health Toronto

Sex: All

Age: 18+

Code: NCT06571916

Recruiting
Active & Responsive

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

for
Kidney Disease
Location: Calgary, Boise ID, Salt Lake City UT, San Francisco CA,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06963827

Phase 3, Recruiting
Active & Responsive

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: Calgary, Vancouver, Seattle WA, Sandy City UT,
Sponsor: Zucara Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT05762107

Phase 2, Recruiting
Active & Responsive

Transauricular Vagus Nerve Stimulation for Chronic Whiplash Associated Disorders

for
Whiplash Associated Disorder (WAD)
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18 - 65

Code: NCT07055373

Recruiting
Active & Responsive

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

for
Diabetes Mellitus, Type 2, Hypertension,
Location: Calgary, Red Deer, Kelowna, Penticton, New Westminster,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07064473

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

The Utility of FDG-PET for Radiation Treatment in NSCLC

for
Lung Neoplasms, Positron Emission Tomography
Location: Calgary
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT00385164

Recruiting
Active & Responsive

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

for
Metastatic Dedifferentiated Liposarcoma,
Location: Calgary, Edmonton, Kalispell MT, Sandpoint ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06422806

Phase 3, Recruiting
Active & Responsive

Assessment of the Relationship Between Cerebral Blood Flow and Heart Rate

for
Cerebrovascular Circulation, Physiology
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18 - 70

Code: NCT04391465

Recruiting
Active & Responsive

Cannabis (THC vs. CBD) in Multiple Sclerosis

for
Multiple Sclerosis
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 26 - 59

Code: NCT06261489

Phase 2, Recruiting
Active & Responsive

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

for
Cardiovascular Disease
Location: Calgary, Edmonton, New Westminster, Vancouver,
Sponsor: Amgen

Sex: All

Age: 50 - 70+

Code: NCT07136012

Phase 3, Recruiting
Active & Responsive

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

for
Rheumatoid Arthritis
Location: Calgary, Saskatoon, Fort Collins CO, Albuquerque NM,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06972446

Phase 2, Recruiting
Active & Responsive

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

for
Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation
Location: Calgary, Spokane WA, Seattle WA, Billings MT, Boise ID,
Sponsor: Chris Goss

Sex: All

Age: 6+

Code: NCT05548283

Recruiting
Active & Responsive

The Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Major Depressive Disorder

for
Depression, Treatment Resistant Depression
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18 - 65

Code: NCT04805879

Phase 2, Phase 3, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

for
Crohn's Disease
Location: Calgary, Lethbridge, Edmonton, New Westminster,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 16 - 70+

Code: NCT06430801

Phase 3, Recruiting
Active & Responsive

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Calgary, New Westminster, Seattle WA, Las Vegas NV,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06233461

Phase 2, Recruiting
Active & Responsive

A Clinical Trial of Fecal Microbiota Transplantation in a Population With Obsessive-compulsive Disorder

for
Obsessive-Compulsive Disorder
Location: Calgary
Sponsor: Valerie Taylor

Sex: All

Age: 18 - 65

Code: NCT05720793

Phase 2, Recruiting
Active & Responsive

A Study to Identify Breast Cancer (IDBC)

for
Breast Cancer Female
Location: Calgary
Sponsor: Syantra Inc.

Sex: Female

Age: 30 - 70+

Code: NCT04495244

Recruiting
Active & Responsive

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

for
Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV,
Location: Calgary, Toronto, Montreal, Halifax
Sponsor: AstraZeneca

Sex: All

Age: 18

Code: NCT07509151

Phase 3, Recruiting
Active & Responsive

Comprehensive Assessment of Neurodegeneration and Dementia

for
Dementia, Mild Cognitive Impairment (MCI),
Location: Calgary, Edmonton, Vancouver, London, Hamilton, Toronto,
Sponsor: McGill University

Sex: All

Age: 50 - 70+

Code: NCT03402919

Recruiting
Active & Responsive

Lupus Landmark Study: A Prospective Registry and Biorepository

for
Systemic Lupus Erythematosus (SLE), Lupus Nephritis,
Location: Calgary, Edmonton, Winnipeg, Beverly Hills CA,
Sponsor: Lupus Research Alliance

Sex: All

Age: 18 - 70+

Code: NCT05934149

Recruiting